ArticleExperimental hematology & oncology2025

NAT10-mediated lipid metabolic reprogramming drives EGFR-TKI resistance in non-small cell lung cancer via ac4C-dependent mRNA stabilization.

Shuai Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.